Odds ratio

Last updated: November 01, 2022

Odds ratio

Watch later

Watch later

Human herpesvirus 8 (Kaposi sarcoma)
Herpes simplex virus
Human herpesvirus 6 (Roseola)
Adenovirus
Parvovirus B19
Human papillomavirus
BK virus (Hemorrhagic cystitis)
JC virus (Progressive multifocal leukoencephalopathy)
Poliovirus
Coxsackievirus
Rhinovirus
Hepatitis A and Hepatitis E virus
Influenza virus
Mumps virus
Measles virus
Respiratory syncytial virus
Human parainfluenza viruses
Yellow fever virus
Zika virus
Hepatitis C virus
West Nile virus
Norovirus
Rotavirus
HIV (AIDS)
Rabies virus
Rubella virus
Prions (Spongiform encephalopathy)
Candida
Plasmodium species (Malaria)
Trypanosoma cruzi (Chagas disease)
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Mechanisms of antibiotic resistance
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anthelmintic medications
Antimalarials
Anti-mite and louse medications
Nuclear structure
DNA structure
Transcription of DNA
Translation of mRNA
Gene regulation
Epigenetics
Amino acids and protein folding
Nucleotide metabolism
DNA replication
Lac operon
DNA damage and repair
Cell cycle
Mitosis and meiosis
DNA mutations
Lesch-Nyhan syndrome
Adenosine deaminase deficiency
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
Gel electrophoresis and genetic testing
ELISA (Enzyme-linked immunosorbent assay)
Karyotyping
DNA cloning
Fluorescence in situ hybridization
Mendelian genetics and punnett squares
Hardy-Weinberg equilibrium
Inheritance patterns
Independent assortment of genes and linkage
Evolution and natural selection
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Fragile X syndrome
Huntington disease
Myotonic dystrophy
Friedreich ataxia
Turner syndrome
Klinefelter syndrome
Prader-Willi syndrome
Angelman syndrome
Cri du chat syndrome
Williams syndrome
Alagille syndrome (NORD)
Achondroplasia
Polycystic kidney disease
Familial adenomatous polyposis
Familial hypercholesterolemia
Marfan syndrome
Multiple endocrine neoplasia
Neurofibromatosis
Tuberous sclerosis
von Hippel-Lindau disease
Albinism
Cystic fibrosis
Gaucher disease (NORD)
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Hemochromatosis
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Leukodystrophy
Niemann-Pick disease types A and B (NORD)
Niemann-Pick disease type C
Phenylketonuria (NORD)
Sickle cell disease (NORD)
Tay-Sachs disease (NORD)
Alpha-thalassemia
Beta-thalassemia
Wilson disease
Alport syndrome
X-linked agammaglobulinemia
Fabry disease (NORD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Hemophilia
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Muscular dystrophy
Wiskott-Aldrich syndrome
Mitochondrial myopathy
Autosomal trisomies: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Miscellaneous genetic disorders: Pathology review
Human development days 1-4
Human development days 4-7
Human development week 2
Human development week 3
Ectoderm
Mesoderm
Endoderm
Development of the placenta
Development of the fetal membranes
Development of twins
Hedgehog signaling pathway
Development of the digestive system and body cavities
Development of the umbilical cord
Development of the cardiovascular system
Fetal circulation
Development of the face and palate
Pharyngeal arches, pouches, and clefts
Development of the gastrointestinal system
Development of the teeth
Development of the tongue
Development of the axial skeleton
Development of the muscular system
Development of the renal system
Development of the reproductive system
Development of the respiratory system
Cellular structure and function
Cell membrane
Selective permeability of the cell membrane
Extracellular matrix
Cell-cell junctions
Endocytosis and exocytosis
Osmosis
Resting membrane potential
Nernst equation
Cytoskeleton and intracellular motility
Cell signaling pathways
Adrenoleukodystrophy (NORD)
Zellweger spectrum disorders (NORD)
Ehlers-Danlos syndrome
Peroxisomal disorders: Pathology review
Introduction to biostatistics
Types of data
Probability
Mean, median, and mode
Range, variance, and standard deviation
Standard error of the mean (Central limit theorem)
Normal distribution and z-scores
Paired t-test
Two-sample t-test
Hypothesis testing: One-tailed and two-tailed tests
One-way ANOVA
Two-way ANOVA
Repeated measures ANOVA
Correlation
Methods of regression analysis
Linear regression
Logistic regression
Type I and type II errors
Sensitivity and specificity
Positive and negative predictive value
Test precision and accuracy
Incidence and prevalence
Relative and absolute risk
Odds ratio
Mortality rates and case-fatality
DALY and QALY
Direct standardization
Indirect standardization
Study designs
Ecologic study
Cross sectional study
Case-control study
Cohort study
Randomized control trial
Clinical trials
Sample size
Disease causality
Selection bias
Information bias
Confounding
Interaction
Prevention
Major depressive disorder
Suicide
Bipolar and related disorders
Major depressive disorder with seasonal pattern
Generalized anxiety disorder
Social anxiety disorder
Panic disorder
Phobias
Obsessive-compulsive disorder
Body focused repetitive disorders
Post-traumatic stress disorder
Schizophrenia
Delirium
Amnesia
Dissociative disorders
Anorexia nervosa
Bulimia nervosa
Cluster A personality disorders
Cluster B personality disorders
Cluster C personality disorders
Somatic symptom disorder
Factitious disorder
Tobacco use disorder
Opioid use disorder
Cannabis use disorder
Cocaine use disorder
Alcohol use disorder
Bruxism
Insomnia
Narcolepsy (NORD)
Erectile dysfunction
Attention deficit hyperactivity disorder
Disruptive, impulse control, and conduct disorders
Learning disability
Fetal alcohol syndrome
Tourette syndrome
Autism spectrum disorder
Rett syndrome
Mood disorders: Pathology review
Amnesia, dissociative disorders and delirium: Pathology review
Personality disorders: Pathology review
Eating disorders: Pathology review
Psychological sleep disorders: Pathology review
Psychiatric emergencies: Pathology review
Drug misuse, intoxication and withdrawal: Hallucinogens: Pathology review
Malingering, factitious disorders and somatoform disorders: Pathology review
Trauma- and stress-related disorders: Pathology review
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Monoamine oxidase inhibitors
Atypical antidepressants
Typical antipsychotics
Atypical antipsychotics
Lithium
Nonbenzodiazepine anticonvulsants
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Psychomotor stimulants

Transcript

Watch video only

In statistics, the words probability and odds are often confused with each other, because they help measure the same thing - the chance that an outcome will occur - and in both cases, we need to know the same two things - the number of times an outcome actually happened, or didn’t happen, and the total number of times an outcome could have happened.

The probability is the number of times an outcome happened divided by the number of times the outcome could have happened, and is often represented by a capital P.

For example, let’s say we want to figure out the probability of having a heart attack for people with hypertension - or high blood pressure.

To do this, we could carry out a cohort study which is where we start with two exposure groups and follow them over time to see if they develop a certain outcome.

We could recruit 100 people with hypertension, The exposed group - and 100 people without hypertension - the non-exposed group - and organize our results in a 2 by 2 table, and keep track of how many of them have heart attacks in the next year.

The two outcomes - heart attack or no heart attack - labeled on the top, and the two exposure groups - hypertension or no hypertension - on the side, and each of the cells inside the box labeled as a, b, c, or d.

Now, let’s say there are 9 people that have heart attacks in the group with hypertension - cell a - and 3 people that have heart attacks in the group without hypertension - cell c.

That means that there are 100 minus 9, or 91, people that didn’t have heart attacks in the group with hypertension - cell b - and 100 minus 3, or 97, people that didn’t have heart attacks in the group without hypertension - cell d.

To calculate the relative risk, we need the probability of having a heart attack in the group with hypertension - so cell a, 9, divided by cell a plus cell b or 100, which gives us 0.09.

We also need the probability of having a heart attack in the group that doesn’t have hypertension - so cell c, 3, divided by cell c plus cell d, 100, which gives us 0.03.

The relative risk is 0.09 divided by 0.03, so 3, which means that people who have hypertension have 3 times the risk of having a heart attack in one year compared to people without hypertension.

The probability of having a heart attack in the past year for people with hypertension is 9 divided by 100, and the result can be written as a decimal - 0.09 - or a percentage - 9%.

On the flip side, we could also find the probability of not having a heart attack for people with hypertension.

A simple way to do this is to subtract the probability of having a heart attack from 1, or 100%.

So, the probability of not having a heart attack for people with hypertension is 1 minus 0.09, which equals 0.91, or 91%.

Now, the relative risk can only be calculated when we have information about incidence, or the probability of a new outcome occurring during a certain time period.

That’s because the word risk implies that hypertension is responsible for causing, or at least partially causing, heart attacks to happen.

And, if hypertension causes heart attacks to happen, then a person would have to have hypertension before they have a heart attack, which can only be measured by incidence - which measures new events.

But sometimes information on incidence can’t be collected, so relative risk can’t be calculated.

For example, case-control studies start with a case group, that already has the outcome, and a control group, that doesn’t have the outcome - and looks at past exposures.

In this situation, odds and odds ratios come in very handy.

Odds compare the probability of an outcome occurring with the probability of an outcome not occurring, so it’s P compared with 1 minus P.

So in our hypertension example, we’d use the probability of having a heart attack - 0.09 - compared with the probability of not having a heart attack, 1 minus 0.09, or 0.91.

Dividing both sides by 0.91, we get 0.0989 compared to 1, and rounding off we can say that it’s 0.1 compared to 1, and multiplying by 10, we get an odds of 1 to 10.

In other words, in one year, for every 1 person with hypertension who has a heart attack, there are 10 people with hypertension who do not have a heart attack.

In fact, the odds will always be slightly higher than the probability of an event, but the odds and the probability end up being very similar when an outcome is rare - specifically when it’s found in less than 10% of the population.

Key Takeaways

The odds ratio (OR) is a statistical measure used to compare the odds of an event occurring in one group to the odds of the same event occurring in another group. It is often used in retrospective studies, such as case-control studies, to compare the likelihood of an outcome (such as a disease or condition) occurring in one group of people compared to another group.

The odds ratio is calculated by dividing the odds of the event occurring in one group by the odds of the event occurring in the other group. For example, if the odds of a disease occurring in group A are 1 in 10, and the odds of the disease occurring in group B are 1 in 20, the odds ratio would be (1/10) / (1/20) = 2. This indicates that the odds of the disease occurring in group A are twice as high as the odds of the disease occurring in group B.